🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

CVS Health Corporation

CVS Healthcare
$94.66 $-0.63 (-0.66%)
Market Cap: $121.07 B
Gurus Holding
20
Popularity Rank
#42
% of Shares Held
3.34%
Net Activity (Q2 2026)
-$218.98 M

Guru Ownership Trend

Guru Analysis for CVS Health Corporation (CVS)

CVS Health Corporation (CVS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 20 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.04 B.

Top institutional holders include Chris Davis and Richard Pzena.

Notably, Prem Watsa has expressed high conviction in this stock, allocating 10.63% of their equity portfolio to it.

Institutional sentiment is currently Bearish. This is evidenced by a $218.98 M net outflow during the quarter.

Recent activity highlights Manning & Napier Group who dramatically increased their stake. Conversely, Paul Tudor Jones reduced exposure by 45.7%.

Key Holders

Top 5 by Value

$1.23 B
$1.22 B
$499.13 M
$378.97 M
$280.5 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$645.56 M
Total Buy Value
New Buys 2
Additions 8
-$864.54 M
Total Sell Value
Reductions 9
Sold Out 4

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
13
Net Buyers
10

FAQs for CVS Health Corporation (CVS)

Major holders include Chris Davis ($1.23 B), Richard Pzena ($1.22 B), Larry Robbins ($499.13 M). According to the latest reported data, 20 tracked investment managers collectively hold approximately 42.7 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $218.98 M, with 10 managers increasing positions and 13 managers reducing holdings.

During the most recent reporting period, 9 managers trimmed their positions, while 4 fully exited CVS. The total reported sell value was $864.54 M.

Yes, 2 managers opened new positions in CVS, and 8 increased their existing holdings. The total reported buy value was $645.56 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
5.27% Reduce -3.1% 11,865,916 $1.23 B Q2 2026
3.57% Reduce -14.6% 11,769,536 $1.22 B Q2 2026
9.09% Reduce -41.1% 4,824,799 $499.13 M Q2 2026
1.08% New Buy 3,663,361 $378.97 M Q2 2026
10.63% 2,712,000 $280.5 M Q2 2026
0.09% Add 1.0% 2,411,937 $248.94 M Q2 2026
0.22% New Buy 1,961,032 $202.87 M Q2 2026
0.75% Add 4.0% 730,110 $75.53 M Q2 2026
0.13% Reduce -14.8% 541,115 $55.98 M Q2 2026
0.11% Add 137.1% 464,885 $48.09 M Q2 2026
0.06% Add 67.6% 441,016 $45.62 M Q2 2026
0.19% Reduce -28.7% 440,972 $45.62 M Q2 2026
0.05% Reduce -45.7% 370,000 $38.28 M Q2 2026
1.37% Reduce -1.2% 98,981 $10.24 M Q2 2026
0.13% Add 942250.0% 94,235 $9.76 M Q2 2026
0.09% Add 0.5% 93,718 $9.7 M Q2 2026
0.00% Add 4.1% 92,010 $9.52 M Q2 2026
4.15% Reduce -17.8% 55,475 $5.74 M Q2 2026
0.03% Add 86.1% 41,017 $4.24 M Q2 2026
0.60% Reduce -40.0% 25,200 $2.61 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form